Only for five genes, namely KAT2A, SMARCA4, BAZ1A, ATAD2 and TRIM28, we observed consistently higher levels and for two genes—KAT2B and SMARCA2—lower levels, respectively, regardless of the tumor type (Figure 1A). This evidence concerns the gene SMARCA4 and neoplasm.